<SEC-DOCUMENT>0001279569-19-000060.txt : 20190114
<SEC-HEADER>0001279569-19-000060.hdr.sgml : 20190114
<ACCEPTANCE-DATETIME>20190114082444
ACCESSION NUMBER:		0001279569-19-000060
CONFORMED SUBMISSION TYPE:	6-K
PUBLIC DOCUMENT COUNT:		3
CONFORMED PERIOD OF REPORT:	20190114
FILED AS OF DATE:		20190114
DATE AS OF CHANGE:		20190114

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			AURORA CANNABIS INC
		CENTRAL INDEX KEY:			0001683541
		STANDARD INDUSTRIAL CLASSIFICATION:	MEDICINAL CHEMICALS & BOTANICAL PRODUCTS [2833]
		IRS NUMBER:				000000000
		STATE OF INCORPORATION:			A1
		FISCAL YEAR END:			0630

	FILING VALUES:
		FORM TYPE:		6-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-38691
		FILM NUMBER:		19523703

	BUSINESS ADDRESS:	
		STREET 1:		500 - 10355 JASPER AVENUE
		CITY:			EDMONTON
		STATE:			A0
		ZIP:			T5J 1Y6
		BUSINESS PHONE:		604-362-5207

	MAIL ADDRESS:	
		STREET 1:		900 - 510 SEYMOUR STREET
		CITY:			VANCOUVER
		STATE:			A1
		ZIP:			V6B 1V5
</SEC-HEADER>
<DOCUMENT>
<TYPE>6-K
<SEQUENCE>1
<FILENAME>aurora_6k.htm
<DESCRIPTION>FORM 6-K
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;</P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 12pt; margin-bottom: 3pt"><DIV STYLE="font-size: 1pt; border-top: Black 4pt solid; border-bottom: Black 2pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="margin: 0"></P>

<P STYLE="margin: 0">&nbsp;</P>

<P STYLE="margin: 0">&nbsp;&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 14pt"><B>UNITED
STATES</B></FONT><BR>
<FONT STYLE="font-size: 14pt"><B>SECURITIES AND EXCHANGE COMMISSION</B></FONT><BR>
<B>Washington, D.C. 20549</B></P>

<P STYLE="font: 18pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>FORM 6-K</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>REPORT OF FOREIGN PRIVATE ISSUER PURSUANT
TO</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B>RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">For the month of <B>January 2019</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Commission File No. <B>001-38691</B></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"><B>AURORA
CANNABIS INC.</B></FONT></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><FONT STYLE="font-size: 24pt"></FONT><BR>
<FONT STYLE="font-size: 10pt">(Translation of registrant's name into English)</FONT></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>500 - 10355 Jasper Avenue</B><BR>
<B>Edmonton, Alberta, T5J 1Y6, Canada</B></P>

<!-- Field: Rule-Page --><DIV ALIGN="CENTER" STYLE="margin-top: 0pt; margin-bottom: 0pt"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 70%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0; text-align: center"><B></B><BR>
(Address of principal executive office)</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark whether the registrant files or will
file annual reports under cover of Form 20-F or Form 40-F</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center">Form 20-F &#9744;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; <B> Form
40-F&nbsp;&nbsp;&#9746;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Indicate by check mark if the registrant is submitting the
Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7) &nbsp;&#9744;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT" STYLE="margin-top: 3pt; margin-bottom: 12pt"><DIV STYLE="font-size: 1pt; border-top: Black 2pt solid; border-bottom: Black 4pt solid; width: 100%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">&nbsp;</P>


<!-- Field: Page; Sequence: 1 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>SUBMITTED HEREWITH</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0; text-align: center; background-color: white"><B>&nbsp;</B></P>

<TABLE CELLSPACING="0" CELLPADDING="0" STYLE="width: 100%; border-collapse: collapse">
<TR STYLE="vertical-align: top">
    <TD STYLE="width: 8%; font: 12pt Times New Roman, Times, Serif; text-align: center; vertical-align: middle; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Exhibits</B></FONT></TD>
    <TD STYLE="width: 2%"></TD>
    <TD STYLE="width: 90%; font: 12pt Times New Roman, Times, Serif; border-bottom: Black 1pt solid"><FONT STYLE="font-size: 10pt"><B>Description&nbsp;</B></FONT></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><FONT STYLE="font-size: 10pt"><A HREF="ex991.htm">99.1</A></FONT></TD>
    <TD>&nbsp;</TD>
    <TD STYLE="font: bold 13pt Arial, Helvetica, Sans-Serif; text-align: left; text-transform: uppercase"><A HREF="ex991.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt; font-weight: normal; text-transform: none">News
Release dated January 14, 2019</FONT></A></TD></TR>
<TR STYLE="vertical-align: top">
    <TD STYLE="font: 12pt Times New Roman, Times, Serif; text-align: center"><A HREF="ex991.htm"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"></FONT></A></TD>
    <TD></TD>
    <TD STYLE="font: 10pt Arial, Helvetica, Sans-Serif; text-align: left"><FONT STYLE="font-family: Times New Roman, Times, Serif; font-size: 10pt"><A HREF="ex991.htm"></A></FONT></TD></TR>
</TABLE>
<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0; text-align: center">&nbsp;</P>


<!-- Field: Page; Sequence: 2 -->
    <DIV STYLE="margin-bottom: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <DIV STYLE="page-break-before: always; margin-top: 6pt"><TABLE CELLPADDING="0" CELLSPACING="0" STYLE="width: 100%"><TR><TD STYLE="text-align: center; width: 100%">&nbsp;</TD></TR></TABLE></DIV>
    <!-- Field: /Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>&nbsp;</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0; text-align: center"><B>SIGNATURE</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Pursuant to the requirements of the Securities Exchange Act
of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0"><B>AURORA CANNABIS INC.</B></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">/s/ <I>Glen Ibbott</I></P>

<!-- Field: Rule-Page --><DIV ALIGN="LEFT"><DIV STYLE="font-size: 1pt; border-top: Black 1pt solid; width: 50%">&nbsp;</DIV></DIV><!-- Field: /Rule-Page -->

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0pt 0 0"><I></I><BR>
Glen Ibbott<BR>
Chief Financial Officer</P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 12pt 0 0">Date: January 14, 2019</P>



<P STYLE="margin: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>2
<FILENAME>ex991.htm
<DESCRIPTION>NEWS RELEASE DATED JANUARY 14, 2019
<TEXT>
<HTML>
<HEAD>
     <TITLE></TITLE>
</HEAD>
<BODY STYLE="font: 10pt Times New Roman, Times, Serif">

<P STYLE="margin: 0; text-align: right"><FONT STYLE="font-family: Arial, Helvetica, Sans-Serif; font-size: 8pt"><B>Exhibit 99.1</B></FONT></P>

<P STYLE="margin: 0; text-align: right">&nbsp;</P>

<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify">&nbsp;</P>

<P STYLE="font: 12pt Times New Roman, Times, Serif; margin: 0 0 12pt 0.25in; text-align: justify">&nbsp;<IMG SRC="logo.jpg" ALT=""></P>



<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: bold 10pt Times New Roman, Times, Serif; margin: 9.45pt 109.85pt 0 109.7pt; text-align: center"></P>

<P STYLE="font: 10pt Times New Roman, Times, Serif; margin: 0"></P>



<P STYLE="margin: 0; text-align: right"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora to Acquire Whistler</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; text-align: center; margin-right: 0; margin-left: 0"><B>A Company with an Iconic
Brand, Offering Organic Certified Cannabis and Organic Certified Cannabis Derivatives</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">TSX: ACB | NYSE: ACB</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">EDMONTON, Jan. 14, 2019 /CNW/ - Aurora Cannabis
Inc. (&quot;Aurora&quot; or the &quot;Company&quot;) (TSX: ACB) (NYSE: ACB) (Frankfurt: 21P; WKN: A1C4WM) announced today that
the Company has entered into a letter of intent (&quot;LOI&quot;) to acquire all the issued and outstanding shares of privately
held Whistler Medical Marijuana Corporation (&quot;Whistler&quot;), in an all-share transaction valued at up to approximately $175
million, including certain milestone payments (the &quot;Transaction&quot;).</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Located in Whistler, British Columbia, Whistler
has developed one of Canada's most iconic cannabis brands, built on quality, award-winning organic certified BC bud. The Transaction
is expected to provide Aurora with a premium and differentiated organic certified product suite, expanding both its medical and
adult-use offerings, and reinforcing Aurora's presence in the well-established west coast cannabis market.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Strategic Rationale</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Whistler has developed a strong reputation
with patients and adult-use consumers alike for providing premium quality cannabis products. Founded in 2013, Whistler is one of
Canada's original ten licensed producers, and was the first licensed producer to obtain organic certification and sell a full suite
of organic certified cannabis products.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Whistler operates two indoor licensed production
facilities, with its first located in Whistler, British Columbia, and the second, a recently licensed, purpose-built, state-of-the-art
facility located a 20-minute drive from the Whistler facility. Once the second facility reaches full capacity (anticipated for
Summer 2019) the facilities are anticipated to have a combined production capacity of over 5,000 kg per year. Whistler sells medical
cannabis derivatives internationally to both Australia and the Cayman Islands, and through the addition of Aurora's deep experience
in completing EU GMP certified facilities and its large global distribution network, Aurora plans to pursue additional international
export opportunities.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Additional transaction highlights:</B></P>

<UL STYLE="list-style-type: disc">

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>History of profitability driven by industry-leading
pricing</B>: Whistler has achieved positive cash flow since 2015, with EBITDA margins in excess of 30%. By ensuring consistency,
quality, and maintaining its organic commitment, Whistler has achieved average selling prices in excess of 50% greater than the
average Canadian&nbsp;medical market, and maintains a similar premium to provinces for adult-use.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Organic Certified EU GMP compliant production</B>: Whistler
is certified by the Fraser Valley Organic Producers Association (FVOPA) and conforms to International Organic Growing Standards.
Whistler's second facility is constructed in compliance with EU GMP standards which, upon certification, will enable the Company
to supply organic certified cannabis products to the European market.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Iconic Whistler brand:</B> Through the premium quality
of its products, as well as the location association with Whistler, British Columbia, which receives over 2.7 million visitors
annually and consistently ranks as one of the top global travel destinations, Whistler has established an iconic brand that resonates
strongly across Canada and international markets.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Broad product portfolio</B>: Whistler has commercialized
more than 30 flower varieties and strain-specific oil products, from an extensive genetics bank of over 150 strains.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Further strengthened presence in Western Canada: </B>Already
one of the strongest performing companies in the Western Canadian adult-use markets along with the Aurora, AltaVie and San Rafael
'71 brands, Whistler will further add a premium organic certified brand with exceptional traction and visibility in British Columbia,
Canada's third most populous province.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Whistler's growing domestic footprint: </B>In addition
to its existing supply arrangements in British Columbia, Saskatchewan and the Yukon, Whistler has received product requests from
Alberta, Manitoba, and Ontario.</LI>

<LI STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0pt 0 12pt"><B>Organic certified large-scale extraction</B>: Whistler
has differentiated large-scale cold-water extraction technology and processes, creating a full suite of organic certified oil products
(including THCA, CBG, and high CBD oils).</LI>

</UL>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Management Commentary</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">&quot;This transaction adds an iconic, organic
certified BC-based brand with exceptional traction and a significant price premium in both the medical and retail markets,&quot;
said Terry Booth, CEO of Aurora. &quot;We intend to accelerate the completion of Whistler's Pemberton expansion project, and leverage
our domestic and international distribution channels to increase market reach for their exceptional products. Whistler has established
leadership in the organic cannabis market, and we look forward to welcoming Christopher and his team to the Aurora family.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Christopher Pelz, CEO and Founder of Whistler,
added, &quot;With its commitment to the highest product quality standards, as well as its large footprint in both the Canadian
and international cannabis markets, Aurora is the ideal partner for Whistler to enhance our growth and margin profile. We feel
there is a strong cultural fit, and believe that Aurora is the right home for us to maintain our organic craft cultivation identity,
while being able to leverage the resources and capabilities of a large and rapidly growing global company.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Neil Belot, Chief Global Business Development
Officer of Aurora, added, &quot;Whistler, the longest operating &nbsp;certified organic cannabis producer in Canada, has an exceptional
track record built on the consistent delivery of premium user experiences. This has resulted in strongly-rated products that command
among the highest prices in the Canadian adult consumer use industry, targeting the premium organic craft segment in both the consumer
and medical markets. Furthermore, as the only cannabis producer in the world-renowned resort town of Whistler, British Columbia,
the company has developed broad brand appeal, both across Canada and internationally.&quot;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Transaction </B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The all-share transaction includes certain
milestone payments in relation to Whistler achieving certain operational objectives. Including these milestone payments, the all-share
transaction values Whistler at up to $175 million.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">The closing of the transaction is subject to
customary closing conditions, including execution of definitive documentation, completion of satisfactory due diligence, receipt
of approval of the shareholders of Whistler, and receipt of applicable third party and regulatory approvals and the satisfaction
of other conditions customary in transactions of this nature.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Stoic Advisory Inc. is acting as financial
advisor and Norton Rose Fulbright Canada LLP is acting as legal advisor to Whistler Medical Marijuana Corp.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">McMillan LLP is acting as legal counsel to
Aurora.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>About Aurora&nbsp;</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Headquartered in Edmonton, Alberta, Canada
with funded capacity in excess of 500,000 kg per annum and sales and operations in 22 countries across five continents, Aurora
is one of the world's largest and leading cannabis companies. Aurora is vertically integrated and horizontally diversified across
every key segment of the value chain, from facility engineering and design to cannabis breeding and genetics research, cannabis
and hemp production, derivatives, high value-add product development, home cultivation, wholesale and retail distribution.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Highly differentiated from its peers, Aurora
has established a uniquely advanced, consistent and efficient production strategy, based on purpose-built facilities that integrate
leading-edge technologies across all processes, defined by extensive automation and customization, resulting in the massive scale
production of high quality product at low cost. Intended to be replicable and scalable globally, our production facilities are
designed to produce cannabis of significant scale, with high quality, industry-leading yields, and low per gram production costs.
Each of Aurora's facilities is built to meet EU GMP standards, and its first production facility, the recently acquired MedReleaf
Markham facility, and its wholly owned European medical cannabis distributor Aurora Deutschland, have achieved this level of certification.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">In addition to the Company's rapid organic
growth and strong execution on strategic M&amp;A, which to date includes 15 wholly owned subsidiary companies &ndash; MedReleaf,
CanvasRX, Peloton Pharmaceutical, Aurora Deutschland, H2 Biopharma, Urban Cultivator, BC Northern Lights, Larssen Greenhouses,
CanniMed Therapeutics, Anandia Labs, HotHouse Consulting, MED Colombia, Agropro, Borela, and ICC Labs &ndash; Aurora is distinguished
by its reputation as a partner and employer of choice in the global cannabis sector, having invested in and established strategic
partnerships with a range of leading innovators, including: Radient Technologies Inc. (TSXV: RTI), Hempco Food and Fiber Inc. (TSXV:
HEMP), Cann Group Ltd. (ASX: CAN), Micron Waste Technologies Inc. (CSE: MWM), Choom Holdings Inc. (CSE: CHOO), Capcium Inc. (private),
Evio Beauty Group (private), Wagner Dimas (private), CTT Pharmaceuticals (OTCC: CTTH), and Alcanna Inc. (TSX: CLIQ).</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Aurora's Common Shares trade on the TSX and
NYSE under the symbol &quot;ACB&quot;, and are a constituent of the S&amp;P/TSX Composite Index.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">For more information about Aurora, please visit
our investor website, investor.auroramj.com&nbsp;</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Terry Booth, CEO<BR>
Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"><B>Forward looking statements&nbsp;</B></P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">This news release includes statements containing
certain &quot;forward-looking information&quot; within the meaning of applicable securities law (&quot;forward-looking statements&quot;).
Forward-looking statements are frequently characterized by words such as &quot;plan&quot;, &quot;continue&quot;, &quot;expect&quot;,
&quot;project&quot;, &quot;intend&quot;, &quot;believe&quot;, &quot;anticipate&quot;, &quot;estimate&quot;, &quot;may&quot;, &quot;will&quot;,
&quot;potential&quot;, &quot;proposed&quot; and other similar words, or statements that certain events or conditions &quot;may&quot;
or &quot;will&quot; occur and include, but are not limited to the completion of definitive agreements and closing of the Transaction.
These statements are only predictions. Various assumptions were used in drawing the conclusions or making the projections contained
in the forward-looking statements throughout this news release. Forward-looking statements are based on the opinions and estimates
of management at the date the statements are made, and are subject to a variety of risks and uncertainties and other factors that
could cause actual events or results to differ materially from those projected in the forward-looking statements. The Company is
under no obligation, and expressly disclaims any intention or obligation, to update or revise any forward-looking statements, whether
as a result of new information, future events or otherwise, except as expressly required by applicable law.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">Neither TSX nor its Regulation Services Provider
(as that term is defined in the policies of Toronto Stock Exchange) accepts responsibility for the adequacy or accuracy of this
release.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:http://www.prnewswire.com/news-releases/aurora-to-acquire-whistler-300777482.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">SOURCE Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">View original content to download multimedia:
http://www.newswire.ca/en/releases/archive/January2019/14/c5008.html</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">%CIK: 0001683541</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin: 0"><B>For further information: </B>For Media: Heather MacGregor, +1.416.509.5416,
heather.macgregor@auroramj.com; For Investors: Marc Lakmaaker, +1.647.269.5523, marc.lakmaaker@auroramj.com; Rob Kelly, +1.647.331.7228,
rob.kelly@auroramj.com; U.S. Investors: Phil Carlson / Elizabeth Barker, KCSA Strategic Communications, Phone: (212) 896-1233 /
(212) 896-1203, Email: pcarlson@kcsa.com / ebarker@kcsa.com</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CO: Aurora Cannabis Inc.</P>

<P STYLE="font: 15pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0">CNW 07:00e 14-JAN-19</P>



<P STYLE="font: bold 24pt Arial, Helvetica, Sans-Serif; margin-right: 0; margin-left: 0"></P>

</BODY>
</HTML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>3
<FILENAME>logo.jpg
<DESCRIPTION>GRAPHIC
<TEXT>
begin 644 logo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  < )4# 2(  A$! Q$!_\0
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M[5;'PO8:7H%[H]II$TDD<-U-YC-N96VK_P!\U^@Y;DT;T9RI_P"+FY>7X?\
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MJ#XG?M5?"CX+^(AH/C/QIIV@:NT2SBUN=V[RV^ZWRK7YC^)?^4RUE_V-%O\
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BPM8^.-#O/#WB72XVT^>VU),2.D>!&X]BI _"BO=J* /_V0$!

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
